We characterized 24 unrelated patients with a deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT) in an attempt to better understand the nature and spectrum of mutations that underlie this prototype-inherited disease. Lymphoblast cell lines derived from each patient were analyzed at multiple molecular levels including the structure and function of the residual HPRT 
Introduction
Hypoxanthine-guanine phosphoribosyltransferase (HPRT)' de- ficiency is an inherited disorder of purine metabolism that has wide-ranging phenotypic effects. A virtual absence of HPRT activity is found in patients with the Lesch-Nyhan syndrome (1) . This X-linked recessive disease is characterized by an overproduction of uric acid as well as the development of uric acid nephrolithiasis, choreoathetoid movements, spasticity and hyperreflexia, severe mental and growth retardation, and a bizarre pattern of patients' self-mutilation characterized by compulsive biting of their fingers and lips (2).
Patients with a partial deficiency of enzyme activity are spared the devastating neurological and behavioral abnormalities that characterize the Lesch-Nyhan syndrome. This latter group of patients usually presents with a severe form of gouty arthritis or uric acid nephrolithiasis in early adulthood (3).
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1. Abbreviations used in this paper: CRM', enzyme positive; HPRT, hypoxanthine-guanine phosphoribosyltransferase; PRPP, 5-phosphoribosyl-l-pyrophosphate; RFLP, restriction fragment length polymorphism.
HPRT deficiency has recently emerged as a prototype for defining the nature and functional consequences of clinically deleterious mutational events and for designing novel therapeutic modalities that attempt to modulate gene expression. Several aspects of this inherited disorder make it particularly amenable to detailed molecular analyses. Our knowledge of normal HPRT protein (4, 5) , mRNA (6, 7) , and gene (8, 9) provides a basis for the precise delineation of the abnormalities present in enzymedeficient patients. The isolation of mutant genes and their products is simplified because the affected male patients are hemizygous for the HPRT locus (1, 3) , and the gene is expressed in a wide variety of human tissues, including cultured cells (10) . We documented in an earlier report the utility and validity of using viral transformed lymphoblasts in tissue culture as a source for the isolation of mutant HPRT gene products (1 1) .
A variety of mutations have now been described in HPRTdeficient patients. Single unique amino acid substitutions have been identified in four dysfunctional enzyme variants; three mutant enzymes were isolated from gouty patients (12) (13) (14) and one was isolated from a Lesch-Nyhan patient (15) . Yang et al. (16) screened a series of Lesch-Nyhan patients for major rearrangements in the HPRT gene and identified unique abnormalities in five unrelated patients. These important preliminary investigations have provoked several more fundamental questions.
A complete deficiency of HPRT activity is not lethal in utero, but does lead to nonreproductive affected males (17) In an attempt to answer these important questions we have undertaken a comprehensive analysis of the molecular basis of HPRT deficiency in a large group of patients. Lymphoblastoid cell lines were established from 24 unrelated enzyme-deficient patients representing both clinical syndromes. These cell lines were characterized at multiple molecular levels including (a) HPRT enzyme concentration, function, and structure, (b) HPRT mRNA concentration and molecular size, and (c) gross structure of the HPRT gene.
wounds usually manifested by self-mutilation ofthe hands and lips. The second clinical subgroup represents a heterogeneous population of patients who (a) present with gouty arthritis and/or uric acid nephrolithiasis at an early age, (b) demonstrate a broad spectrum of HPRT activity in erythrocytes (from undetectable to -50% of activity), (c) usually have completely normal neurological function, but may have mild to moderate neurological abnormalities (e.g., learning disabilities or hyperreflexia), and (d) never manifest the compulsive self-destructive behavior that is characteristic of the Lesch-Nyhan syndrome.
Lymphoblastoid cell lines were established for each patient by EpsteinBarr virus-mediated transformation of peripheral blood B lymphocytes. Methods used in the establishment and maintenance of lymphoblastoid cell lines have been described (1 1). Cell lines GM2292, GM 1899, and GM6804 were obtained from The Human Mutant Cell Repository, Camden, NJ.
Enzyme assays. Membrane-free protein extracts were prepared from freshly harvested lymphoblast cultures as described (I 1). Sensitive radiochemical and immunochemical techniques were used to quantify HPRT enzyme activity (18) Protein blot analysis. Protein extracts were subjected to polyacrylamide gel electrophoresis in the presence or absence of sodium dodecyl sulfate (SDS) as described previously. Electrophoretic transfer of proteins from nondenaturing gels to nitrocellulose paper has been well described (1 1). Proteins were transferred from SDS gels to nitrocellulose paper as described by Towbin et al. (20) except that the transfer was carried out for 3 h at 50 V. Detection of HPRT in situ, after transfer from either nondenaturing or SDS gels, was effected immunochemically using previously published methods (I 1).
Analysis ofradiolabeledHPRTproteins. Lymphoblasts from a normal male subject and from patient D.B. were labeled in culture with
[35S]methionine. "S-labeled HPRT protein was purified to radiochemical homogeneity by immunoprecipitation with a highly specific antibody.
Immunoprecipitates were analyzed by SDS-polyacrylamide gel electrophoresis. The labeling, purification, and electrophoretic analysis of
[35S]HPRT has been described (I 1).
RNA isolation and Northern blot analysis. Total RNA was isolated in the presence of guanidine-HCI as described (21) . 50 ,g of RNA was electrophoresed in a 0.8% agarose gel, transferred to nitrocellulose, and hybridized with "P-deoxycytidine triphosphate (dCTP) nick-translated HPRT cDNA (21) .
DNA isolation and Southern blot analysis. High-molecular-weight * Mean; (n) = number of determinations. § Mean± I SD; (n) = number of determinations. "I Obtained from reference 11. DNA was isolated from cultured lymphoblasts as described (21) . DNA was digested to completion with one ofseveral restriction endonucleases under conditions recommended by the manufacturer (Bethesda Research Laboratories, Gaithersburg, MD, and New England Biolabs, Beverly, MA). Restricted DNA was fractionated in 0.8% agarose gels, transferred to nitrocellulose paper, and probed with 32P-labeled DNA as described (16 Membrane-free extracts of the previously uncharacterized patients, D.B., K.T., and D.G., were subjected to similar electrophoretic analysis, as shown in Fig. 1 HPRTLondon, which exhibited a slightly lower apparent subunit molecular weight (11, 19) . The protein blot technique was employed to quickly screen for marked alterations in apparent subunit molecular weight.
Membrane-free extracts from a normal cell line, the three previously uncharacterized enzyme-positive cell lines, and selected known HPRT variants, were electrophoresed in the presence of SDS, and the HPRT enzymes were detected immunochemically as described (Fig. 2) . A single predominate molecular species with an apparent subunit molecular weight equal to 25,000, as well as multiple additional nonpredominate bands, were detected in each cell line studied. Several observations indicate that the multiple nonpredominate bands are due to nonspecific binding of antibody, and that the 25,000-mol-wt species represents bonafide HPRT. All bands except the 25,000-mol-wt band are present when (a) control serum is used in place of HPRT antiserum (data not shown), or (b) extracts from enzymedeficient cell lines lacking detectable HPRT immunoreactive pG N DBI -S°N KT protein were analyzed (data not shown). The apparent subunit molecular weight of HPRT from K.T. and D.G. is indistinguishable from normal HPRT (lane N). However, the migration of HPRT from D.B. appears to be slightly faster than normal HPRT and, therefore, the apparent subunit molecular weight somewhat lower.
We attempted to confirm the subtle decrease in apparent subunit molecular weight of HPRT from D.B. using an alternative method. HPRT from D.B. and from a normal lymphoblastoid cell line was labeled in culture with [35S]methionine and purified to homogeneity by immunoprecipitation. The radiochemically homogeneous enzymes were subjected to SDSpolyacrylamide gel electrophoresis and directly visualized by autoradiography (Fig. 3) Lesch-Nyhan patients and 8 of 9 gouty patients (Fig. 4) (Fig. 4) . We estimate the sensitivity of this technique to be >5% normal HPRT mRNA concentration.
GM6804 was the only cell line in which the HPRT mRNA exhibited altered electrophoretic properties; this abnormal mRNA migrated at an abnormally slow rate, consistent with an increase in molecular size from 1.6 to 1.8 kb. Similar findings have been reported in fibroblasts derived from this patient (16 (27) .
Two HPRT-linked RFLPs have been described. Nussbaum reported a three-allele Bam H1 RFLP that occurs within the HPRT gene (28) . These alleles are expressed phenotypically on Southern blots as three distinct pairs of fragments: a 22-kb, 25-kb pair; a 12-kb, 25-kb pair; and a 22-kb, 18-kb pair. An additional two-allele Taq I RFLP has been reported for an anonymous sequence (DXS-10) separate from, but closely linked to (95% confidence limits 0 < 15 cM), the HPRT locus (29). These alleles are represented as 5 or 7 kb fragments on Southern anal-AC BS 44 \. I.-ysis. These RFLP patterns can be combined to establish six haplotypes, four of which are represented in this group of patients (Fig. 5) . The most frequent haplotype (68%) was that combining the 22-kb, 25 Table III . This marked molecular heterogeneity provides further support for the concept originally proposed by Haldane, that X-linked recessive disorders are sustained in the population by the constant introduction of new mutations. Furthermore, the present study demonstrates that each category of mutation, as outlined in Fig. 6 , is represented in both clinical syndromes. However, mutations with less deleterious effects on enzyme function in vivo (e.g., most amino acid substitutions that affect enzyme function but not enzyme concentration) are more often associated with patients who are spared the devastating neurologic and behavioral abnormalities of Lesch-Nyhan syndrome.
In conclusion, we analyzed a large population of unrelated HPRT-deficient patients with respect to abnormalities in the HPRT enzyme, mRNA, and gene. This study provides insight into the spectrum and prevalence of mutations that underlie this heterogeneous disorder and illustrates the kind ofmutations that can lead to inherited disease in man.
